January AI today unveiled new advancements to its AI-driven metabolic health app that helps users monitor and take control of ...

Luna Diabetes announced that it launched its pivotal trial for Luna, the company's miniature automated insulin delivery ...

BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity ...

Medtronic (NYSE: MDT) announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated ...

Know Labs (NYSE:KNW) announced today that it appointed a new chief science officer (CSO) and interim chief technology officer ...

ViCentra announced that it received CE mark approval for its Kaleido insulin pump under European Medical Device Regulation ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

Ypsomed announced today that it opened a new production hall at its German site in Schwerin to increase auto-injector ...

Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO.

Clearside Biomedical today announced that the ODYSSEY study of its drug-device combination achieved its primary and secondary ...

Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM ...

The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 ...